Associate Justice Neil Gorsuch (AP Photo/J. Scott Applewhite)

SCO­TUS rules unan­i­mous­ly in fa­vor of Sanofi and Re­gen­eron in PC­SK9 patent spat with Am­gen

In a close­ly fought patent bat­tle be­tween PC­SK9 ri­vals Am­gen and Sanofi/Re­gen­eron, the Supreme Court ruled unan­i­mous­ly on Thurs­day that Am­gen can­not mo­nop­o­lize the mar­ket for any and every an­ti­body that binds to ar­eas of the sweet spot of PC­SK9.

The win for Sanofi and Re­gen­eron is a set­back for com­pa­nies like Am­gen who are look­ing to patent broad cat­e­gories of an­ti­bod­ies, but can­not pro­duce each of the an­ti­bod­ies that might fall in­to such a cat­e­go­ry.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.